Evidence map›Paper›PMID 22493595›Full record

ArticleFrontiers in microbiology2012

Dysregulation of ion homeostasis by antifungal agents.

Yongqiang Zhang, Sabina Muend, Rajini Rao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Inferring Therapeutic Targets inLife (Basel, Switzerland) · 2022
    Article
  3. Antifungal Activity ofMolecules (Basel, Switzerland) · 2022
    Article
  4. Article
  5. Article
  6. Promising Antifungal Targets AgainstFrontiers in cellular and infection microbiology · 2018
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yongqiang ZhangDepartment of Physiology, The Johns Hopkins University School of Medicine Baltimore, MD, USA.
Sabina Muend
Rajini Rao
Johns Hopkins Medicine · USJohns Hopkins University · US

Funding

Cellular Basis for the Antifungal Activity of AmiodaroneR01AI065983 · NIAID · JOHNS HOPKINS UNIVERSITY · PI RAO, RAJINI · 2006 to 2010
$2.1M
NIAID NIH HHS R01 AI065983
6 · The paper itself

Abstract

Ion-signaling and transduction networks are central to fungal development and virulence because they regulate gene expression, filamentation, host association, and invasion, pathogen stress response and survival. Dysregulation of ion homeostasis rapidly mediates cell death, forming the mechanistic basis by which a growing number of amphipathic but structurally unrelated compounds elicit antifungal activity. Included in this group is carvacrol, a terpenoid phenol that is a prominent component of oregano and other plant essential oils. Carvacrol triggers an early dose-dependent Ca(2+) burst and long lasting pH changes in the model yeast Saccharomyces cerevisiae. The distinct phases of ionic transients and a robust transcriptional response that overlaps with Ca(2+) stress and nutrient starvation point to specific signaling events elicited by plant terpenoid phenols, rather than a non-specific lesion of the membrane, as was previously considered. We discuss the potential use of plant essential oils and other agents that disrupt ion-signaling pathways as chemosensitizers to augment conventional antifungal therapy, and to convert fungistatic drugs with strong safety profiles into fungicides.

Indexed as

amiodaronecalcium burstCandida albicanscarvacrolpHplant essential oilsterpenoid phenolvacuole

Identifiers

PMID22493595
PMCPMC3319912
OpenAlexW2032413924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.